Developer docs
API playgroundTry for free, no card

Search company profiles

Perelman School of Medicine at the University of Pennsylvania

Full company profile

uuid0003ol9

Namestring
Perelman School of Medicine at the University of Pennsylvania
Legal namestring
Perelman School of Medicine at the University of Pennsylvania
Websiteurl
med.upenn.edu
Company typeenum
Private
Founded yearint
1765
Descriptiontext

The Perelman School of Medicine at the University of Pennsylvania is the oldest medical school in the United States, founded in 1765 in Philadelphia. It operates as a constituent school of the private non-profit University of Pennsylvania, with 2,900+ full-time faculty, 6,800+ total employees, 761 MD students, 842 PhD students, 222 MD-PhD students, and 1,900+ residents and fellows. The institution runs over 50 specialized research centers and institutes, including the Abramson Cancer Center and the Center for Cellular Immunotherapies, and delivers clinical care through six affiliated hospitals: Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Pennsylvania Hospital, Chester County Hospital, Lancaster General Hospital, and Penn Medicine Princeton Health, plus a pediatric partnership with Children's Hospital of Philadelphia.

The school's core technology stack spans basic science, translational, and clinical research across oncology, cardiology, immunology, neuroscience, and gene therapy. Notable proprietary capabilities include CAR T-cell therapy (tisagenlecleucel), which has demonstrated 10-year remissions in large B-cell and follicular lymphoma patients; an ultrathin flexible electronic mesh that integrates with developing pancreatic tissue to mature stem-cell-derived islet cells for diabetes care; the TIE2 protein inhibitor rebastinib for cerebral cavernous malformations; an mRNA nanoparticle vaccine platform; and the FRAME curriculum integrating AI, VR/AR, and personalized learning into medical education.

Penn's business model rests on three revenue streams: research grants and sponsored programs ($982M in FY2022, primarily NIH-funded), clinical care revenue from the six-hospital Penn Medicine system, and tuition/fees from MD, PhD, combined-degree, master's, certificate, postdoctoral, and continuing medical education programs. The school is governed by the University of Pennsylvania Board of Trustees and led by Dean Jonathan A. Epstein, MD. Major philanthropic anchors include $225M from Raymond and Ruth Perelman (2011), $100M and $25M from the Abramsons (1997/2010), and recent $8M from the RTW Foundation (2026) and $25M from PCORI (2025).

Short descriptiontext

The Perelman School of Medicine at the University of Pennsylvania is the oldest U.S. medical school (founded 1765), training physicians and researchers while delivering clinical care through six affiliated hospitals and producing $982M in annual sponsored research, including pioneering CAR T-cell therapy and gene therapy programs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersPhiladelphia, United States
HQ citystring
Philadelphia
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical education, biomedical research, clinical care, academic medicine, graduate medical training
Industry5 codes
1Medical Schools (MD/DO Granting)
CodeEDAHAGABPrimaryYes
2Biomedical Sciences & Medical Research Institutes (University-Based)
CodeEDAHAGAIPrimaryNo
3Academic Medical Centers & Teaching Hospitals (University-Affiliated)
CodeEDAHAGAAPrimaryNo
4Health & Biomedical Research Universities (Academic Medical Center–Affiliated)
CodeEDAHABACPrimaryNo
5Schools of Nursing
CodeEDAHAGACPrimaryNo
NAICS code4 codes
  • Colleges, Universities, and Professional Schools6113
  • Colleges, Universities, and Professional Schools61131
  • Colleges, Universities, and Professional Schools611310
  • Specialty (except Psychiatric and Substance Abuse) Hospitals62231
SIC code4 codes
  • Services-Health Services8000
  • Services-Commercial Physical & Biological Research8731
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Academic Medical Center
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Research Grants and Sponsored Programs
TypeSubscription Recurring
Description

Federal and private research funding primarily from NIH, other government agencies, and foundations. In FY2022, total sponsored program awards reached $982 million.

med.upenn.edu
2Clinical Care Revenue
TypeSubscription Recurring
Description

Patient care services delivered through six affiliated hospitals including Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Pennsylvania Hospital, and regional facilities.

med.upenn.edu
3Medical Education Tuition
TypeSubscription Recurring
Description

MD program tuition, PhD programs, MD-PhD programs, master's and certificate programs, and continuing medical education.

med.upenn.edu
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Perelman School of Medicine at the University of Pennsylvania is an academic medical center that delivers medical education (MD, PhD, dual-degree, master's, certificate, postdoctoral, and continuing medical education programs), conducts biomedical and clinical research across disciplines including oncology, cardiology, immunology, neuroscience, and gene therapy, and provides patient care through six affiliated hospitals in the Penn Medicine Health System.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 10-year remissions in large B-cell lymphoma patients receiving CAR T-cell therapy
+2 more records
Product overview1 text field

The Perelman School of Medicine at the University of Pennsylvania is the nation's first medical school (founded 1765) offering a comprehensive portfolio of educational programs, research initiatives, and clinical care services. The educational offerings include an MD program, PhD programs through Biomedical Graduate Studies, combined degree programs (MD/PhD and MD/Master's variants), Master's & Certificate Programs, visiting student rotations, postdoctoral training, and continuing medical education. The institution operates over 50 research centers and institutes including the Abramson Cancer Center and Center for Cellular Immunotherapies, advancing biomedical research in areas such as cancer, immunotherapy, cardiovascular disease, and neurosciences. Clinical care is delivered through affiliated hospitals including the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, and Pennsylvania Hospital.

Product and service8 records
1MD Program
CategoryEducational Program
2PhD Programs (Biomedical Graduate Studies)
CategoryEducational Program
3Combined Degree and Physician Scholar Programs
CategoryEducational Program
4Master's & Certificate Programs (MaC)
CategoryEducational Program
5Visiting Students Program
CategoryEducational Program
6Biomedical Postdoctoral Programs
CategoryEducational Program
7Continuing Medical and Interprofessional Education
CategoryEducational Program
8FRAME Initiative (Future of Medical Education)
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-16
Description

$25 million six-year clinical trial partnership to test whether smartphone gamification can sustainably increase physical activity among 18,000 high-risk adults and reduce cardiovascular events. The fully remote study enrolls participants across 15 states and the District of Columbia.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-28
Description

Research collaboration to develop next-generation T cell immunotherapies for solid tumors, focusing on peptide HLA binder discovery, bispecific T-cell engagers, and novel CAR architectures, with the goal of clinical development after establishing a company and securing seed funding.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-28
Description

Collaborative partnership for developing next-generation T cell immunotherapies for solid tumors alongside Myrio Therapeutics, focusing on peptide HLA binder discovery and novel CAR architectures.

4Botswana-UPenn Partnership
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Long-standing partnership with University of Botswana for capacity-building, academic partnerships, and clinical rotations. Includes research collaborations in HIV/AIDS, TB, adolescent health, and global cardiovascular disease.

med.upenn.edu
Strategic tierMajorTypeStrategic or Co-development Partner
Description

International partnership for capacity-building, international medical education, academic partnerships, medical education development, faculty development, global nursing, graduate medical education, and simulation training in Vietnam.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Affiliated pediatric hospital partnership for clinical care, research, and medical education, including pediatric residency training and collaborative research programs.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Harvard Medical School is a peer private medical school with a comparable mix of medical education, biomedical research, and affiliated teaching hospitals. Both are top-tier AMC-affiliated research institutions competing for NIH funding and faculty recruits.

TypeDirect peer
Description

UCSF School of Medicine is a peer top-tier research medical school with a large NIH-funded research portfolio and affiliated health system. Both compete for biomedical research funding and faculty recruits.

TypeDirect peer
Description

Yale School of Medicine is a peer private research medical school with Yale New Haven Health. Both are top-10 AMCs competing for NIH funding, faculty, and high-acuity patients.

TypeDirect peer
Description

Columbia's medical school is a peer Ivy League private medical school with affiliated NewYork-Presbyterian Hospital. Both share similar funding sources, biomedical research focus, and patient populations.

TypeDirect peer
Description

Stanford Medicine is a peer private academic medical center combining research, education, and clinical care with a similarly high concentration of NIH funding and technology-driven research. Both lead in biomedical innovation and translation.

TypeDirect peer
Description

Duke School of Medicine is a peer private research medical school with affiliated Duke University Health System. Both compete in biomedical research, MD/PhD training, and specialty clinical care.

TypeDirect peer
Description

Weill Cornell is a peer private medical school affiliated with NewYork-Presbyterian. Both compete for biomedical research funding and serve overlapping patient populations in the Northeast.

TypeDirect peer
Description

WashU Med is a peer private research medical school with a large NIH funding base and major affiliated hospitals (Barnes-Jewish). Both are consistently top-ranked for research and physician training.

TypeDirect peer
Description

Johns Hopkins School of Medicine is one of Penn's closest peers - a private research medical school with a major affiliated hospital system and historically large NIH funding base. Both compete for top research rankings and specialty referrals.

TypeDirect peer
Description

NYU Grossman is a peer private medical school with major research funding and a large affiliated hospital system. Penn actively partners with NYU Langone Health on next-generation T cell immunotherapy research, underscoring direct comparability.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Perelman School of Medicine at the University of Pennsylvania

Academic Medical Centermed.upenn.edu

The Perelman School of Medicine at the University of Pennsylvania is the oldest U.S. medical school (founded 1765), training physicians and researchers while delivering clinical care through six affiliated hospitals and producing $982M in annual sponsored research, including pioneering CAR T-cell therapy and gene therapy programs.

What Perelman School of Medicine at the University of Pennsylvania does

The Perelman School of Medicine at the University of Pennsylvania is the oldest medical school in the United States, founded in 1765 in Philadelphia. It operates as a constituent school of the private non-profit University of Pennsylvania, with 2,900+ full-time faculty, 6,800+ total employees, 761 MD students, 842 PhD students, 222 MD-PhD students, and 1,900+ residents and fellows. The institution runs over 50 specialized research centers and institutes, including the Abramson Cancer Center and the Center for Cellular Immunotherapies, and delivers clinical care through six affiliated hospitals: Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Pennsylvania Hospital, Chester County Hospital, Lancaster General Hospital, and Penn Medicine Princeton Health, plus a pediatric partnership with Children's Hospital of Philadelphia.

The school's core technology stack spans basic science, translational, and clinical research across oncology, cardiology, immunology, neuroscience, and gene therapy. Notable proprietary capabilities include CAR T-cell therapy (tisagenlecleucel), which has demonstrated 10-year remissions in large B-cell and follicular lymphoma patients; an ultrathin flexible electronic mesh that integrates with developing pancreatic tissue to mature stem-cell-derived islet cells for diabetes care; the TIE2 protein inhibitor rebastinib for cerebral cavernous malformations; an mRNA nanoparticle vaccine platform; and the FRAME curriculum integrating AI, VR/AR, and personalized learning into medical education.

Penn's business model rests on three revenue streams: research grants and sponsored programs ($982M in FY2022, primarily NIH-funded), clinical care revenue from the six-hospital Penn Medicine system, and tuition/fees from MD, PhD, combined-degree, master's, certificate, postdoctoral, and continuing medical education programs. The school is governed by the University of Pennsylvania Board of Trustees and led by Dean Jonathan A. Epstein, MD. Major philanthropic anchors include $225M from Raymond and Ruth Perelman (2011), $100M and $25M from the Abramsons (1997/2010), and recent $8M from the RTW Foundation (2026) and $25M from PCORI (2025).

Perelman School of Medicine at the University of Pennsylvania firmographics

Firmographics
Name
Perelman School of Medicine at the University of Pennsylvania
Legal name
Perelman School of Medicine at the University of Pennsylvania
Website
https://med.upenn.edu
Company type
Private
Founded year
1765
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
The Perelman School of Medicine at the University of Pennsylvania is the oldest U.S. medical school (founded 1765), training physicians and researchers while delivering clinical care through six affiliated hospitals and producing $982M in annual sponsored research, including pioneering CAR T-cell therapy and gene therapy programs.
Ownership category
akta.pro rank

Perelman School of Medicine at the University of Pennsylvania industry classification

Industry
Product category
Academic Medical Center
NAICS
Colleges, Universities, and Professional Schools (6113), Colleges, Universities, and Professional Schools (61131), Colleges, Universities, and Professional Schools (611310), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)
SIC
Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro primary industry
Medical Schools (MD/DO Granting) (EDAHAGAB)
akta.pro secondary industries
Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI), Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Health & Biomedical Research Universities (Academic Medical Center–Affiliated) (EDAHABAC), Schools of Nursing (EDAHAGAC)

Keywords

  • Medical education
  • Biomedical research
  • Clinical care
  • Academic medicine
  • Graduate medical training

Where Perelman School of Medicine at the University of Pennsylvania is headquartered

Location

Headquarters

HQ city
Philadelphia
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Perelman School of Medicine at the University of Pennsylvania business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Research Grants and Sponsored Programs: Federal and private research funding primarily from NIH, other government agencies, and foundations. In FY2022, total sponsored program awards reached $982 million.
  2. Clinical Care Revenue: Patient care services delivered through six affiliated hospitals including Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Pennsylvania Hospital, and regional facilities.
  3. Medical Education Tuition: MD program tuition, PhD programs, MD-PhD programs, master's and certificate programs, and continuing medical education.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Perelman School of Medicine at the University of Pennsylvania product offering

Product offering

Core offering

Perelman School of Medicine at the University of Pennsylvania is an academic medical center that delivers medical education (MD, PhD, dual-degree, master's, certificate, postdoctoral, and continuing medical education programs), conducts biomedical and clinical research across disciplines including oncology, cardiology, immunology, neuroscience, and gene therapy, and provides patient care through six affiliated hospitals in the Penn Medicine Health System.

Product overview

The Perelman School of Medicine at the University of Pennsylvania is the nation's first medical school (founded 1765) offering a comprehensive portfolio of educational programs, research initiatives, and clinical care services. The educational offerings include an MD program, PhD programs through Biomedical Graduate Studies, combined degree programs (MD/PhD and MD/Master's variants), Master's & Certificate Programs, visiting student rotations, postdoctoral training, and continuing medical education. The institution operates over 50 research centers and institutes including the Abramson Cancer Center and Center for Cellular Immunotherapies, advancing biomedical research in areas such as cancer, immunotherapy, cardiovascular disease, and neurosciences. Clinical care is delivered through affiliated hospitals including the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, and Pennsylvania Hospital.

Differentiator

Problem solved

Functional benefit

Products and services

  • MD Program
  • PhD Programs (Biomedical Graduate Studies)
  • Combined Degree and Physician Scholar Programs
  • Master's & Certificate Programs (MaC)
  • Visiting Students Program
  • Biomedical Postdoctoral Programs
  • Continuing Medical and Interprofessional Education
  • FRAME Initiative (Future of Medical Education)

Quantifiable outcome

  • 10-year remissions in large B-cell lymphoma patients receiving CAR T-cell therapy
  • +2 more outcomes

Companies that use Perelman School of Medicine at the University of Pennsylvania

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Perelman School of Medicine at the University of Pennsylvania technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Perelman School of Medicine at the University of Pennsylvania partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and major.

  • Ascension Health SystemcoreStrategic or Co-development Partner · 16 December 2025$25 million six-year clinical trial partnership to test whether smartphone gamification can sustainably increase physical activity among 18,000 high-risk adults and reduce cardiovascular events. The fully remote study enrolls participants across 15 states and the District of Columbia.
  • Myrio TherapeuticscoreStrategic or Co-development Partner · 28 October 2025Research collaboration to develop next-generation T cell immunotherapies for solid tumors, focusing on peptide HLA binder discovery, bispecific T-cell engagers, and novel CAR architectures, with the goal of clinical development after establishing a company and securing seed funding.
  • NYU Langone HealthcoreStrategic or Co-development Partner · 28 October 2025Collaborative partnership for developing next-generation T cell immunotherapies for solid tumors alongside Myrio Therapeutics, focusing on peptide HLA binder discovery and novel CAR architectures.
  • Botswana-UPenn PartnershipcoreStrategic or Co-development PartnerLong-standing partnership with University of Botswana for capacity-building, academic partnerships, and clinical rotations. Includes research collaborations in HIV/AIDS, TB, adolescent health, and global cardiovascular disease.
  • Vingroup-Penn Alliance (Vietnam)majorStrategic or Co-development PartnerInternational partnership for capacity-building, international medical education, academic partnerships, medical education development, faculty development, global nursing, graduate medical education, and simulation training in Vietnam.
  • Children's Hospital of Philadelphia (CHOP)coreStrategic or Co-development PartnerAffiliated pediatric hospital partnership for clinical care, research, and medical education, including pediatric residency training and collaborative research programs.

Scale indicators8 records

Recent moves4 records

Expansion highlights6 records

Perelman School of Medicine at the University of Pennsylvania competitors and assessment

Company assessment

Direct peers

  • Harvard Medical School: Harvard Medical School is a peer private medical school with a comparable mix of medical education, biomedical research, and affiliated teaching hospitals. Both are top-tier AMC-affiliated research institutions competing for NIH funding and faculty recruits.
  • UCSF School of Medicine: UCSF School of Medicine is a peer top-tier research medical school with a large NIH-funded research portfolio and affiliated health system. Both compete for biomedical research funding and faculty recruits.
  • Yale School of Medicine: Yale School of Medicine is a peer private research medical school with Yale New Haven Health. Both are top-10 AMCs competing for NIH funding, faculty, and high-acuity patients.
  • Columbia University Vagelos College of Physicians and Surgeons: Columbia's medical school is a peer Ivy League private medical school with affiliated NewYork-Presbyterian Hospital. Both share similar funding sources, biomedical research focus, and patient populations.
  • Stanford School of Medicine: Stanford Medicine is a peer private academic medical center combining research, education, and clinical care with a similarly high concentration of NIH funding and technology-driven research. Both lead in biomedical innovation and translation.
  • Duke University School of Medicine: Duke School of Medicine is a peer private research medical school with affiliated Duke University Health System. Both compete in biomedical research, MD/PhD training, and specialty clinical care.
  • Weill Cornell Medicine: Weill Cornell is a peer private medical school affiliated with NewYork-Presbyterian. Both compete for biomedical research funding and serve overlapping patient populations in the Northeast.
  • Washington University School of Medicine in St. Louis: WashU Med is a peer private research medical school with a large NIH funding base and major affiliated hospitals (Barnes-Jewish). Both are consistently top-ranked for research and physician training.
  • Johns Hopkins University School of Medicine: Johns Hopkins School of Medicine is one of Penn's closest peers - a private research medical school with a major affiliated hospital system and historically large NIH funding base. Both compete for top research rankings and specialty referrals.
  • NYU Grossman School of Medicine: NYU Grossman is a peer private medical school with major research funding and a large affiliated hospital system. Penn actively partners with NYU Langone Health on next-generation T cell immunotherapy research, underscoring direct comparability.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Perelman School of Medicine at the University of Pennsylvania social profiles

Digital presence

Perelman School of Medicine at the University of Pennsylvania financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Perelman School of Medicine at the University of Pennsylvania leadership team

Management profile

Number of profiles

Profiles11 records

Perelman School of Medicine at the University of Pennsylvania funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Perelman School of Medicine at the University of Pennsylvania M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Perelman School of Medicine at the University of Pennsylvania

What does Perelman School of Medicine at the University of Pennsylvania do?

Perelman School of Medicine at the University of Pennsylvania is an academic medical center that delivers medical education (MD, PhD, dual-degree, master's, certificate, postdoctoral, and continuing medical education programs), conducts biomedical and clinical research across disciplines including oncology, cardiology, immunology, neuroscience, and gene therapy, and provides patient care through six affiliated hospitals in the Penn Medicine Health System.

Is Perelman School of Medicine at the University of Pennsylvania a public or private company?

Perelman School of Medicine at the University of Pennsylvania is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Perelman School of Medicine at the University of Pennsylvania founded?

Perelman School of Medicine at the University of Pennsylvania was founded in 1765. It employs 5,001 to 10,000 people.

Where is Perelman School of Medicine at the University of Pennsylvania based?

Perelman School of Medicine at the University of Pennsylvania is headquartered in Philadelphia, United States, in the North America region.

How does Perelman School of Medicine at the University of Pennsylvania make money?

Three revenue lines are on record. Research Grants and Sponsored Programs are the primary driver. The others are clinical Care Revenue and medical Education Tuition.

Who are Perelman School of Medicine at the University of Pennsylvania's main competitors?

Direct peers on record are Harvard Medical School, UCSF School of Medicine, Yale School of Medicine, Columbia University Vagelos College of Physicians and Surgeons, Stanford School of Medicine, Duke University School of Medicine, Weill Cornell Medicine, Washington University School of Medicine in St. Louis, Johns Hopkins University School of Medicine and NYU Grossman School of Medicine.

Does Perelman School of Medicine at the University of Pennsylvania have an API?

No public API is recorded for Perelman School of Medicine at the University of Pennsylvania.

What industry is Perelman School of Medicine at the University of Pennsylvania in?

Perelman School of Medicine at the University of Pennsylvania's product category is Academic Medical Center. Its primary akta.pro industry code is EDAHAGAB, Medical Schools (MD/DO Granting), with a secondary code of EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based). Its NAICS code is 6113 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Knowledge at WhartonBioengineering a ‘natural connection’ for rotator cuff repairResearchers at the Perelman School of Medicine have developed a scaffold designed to mimic the natural transition from tendon to fibrocartilage to bone at the rotator cuff tendon-to-bone interface, according to a paper in Science Advances. Senior author Su Chin Heo said the scaffold aims to provide localized biomechanical cues for more complete healing, addressing failures in large injuries and degeneration cases.MedicalxpressHow DNA folding controls immune gene activity in T cellsResearchers at the Perelman School of Medicine at the University of Pennsylvania published in Immunity that the three-dimensional folding of DNA at a super-enhancer locus controls when the Ets1 and Fli1 genes are switched on in T cells. Using imaging and mice lacking the super-enhancer, they found the folding pattern changes as T cells mature into Th1 cells, and removal of the element disrupts gene activity.Mirage NewsNatural Connections Key to Enhanced Rotator Cuff RepairResearchers at the University of Pennsylvania's Perelman School of Medicine developed a scaffold designed to mimic the natural transition from tendon to cartilage-like tissue to bone at rotator cuff repair sites, published in Science Advances. The team used nanofibers from cow Achilles tendons, hyaluronic acid and a citrate-based porous material, and found it guided stem cells and promoted more organized tissue formation in animal models. The system must pass large-animal trials before human use.NaturalNewsBlogsTRF2 Protein Found to Preserve Muscle Stem Cells for Injury Repair, Study Says â NaturalNews.comResearchers at the Perelman School of Medicine at the University of Pennsylvania discovered that TRF2, a protein known for protecting chromosome ends, also preserves muscle stem cell identity and facilitates muscle repair. In experiments, mice lacking TRF2 experienced a decline in muscle stem cells and accumulation of scar tissue after injury, suggesting TRF2's critical role in muscle regeneration. The findings may guide future research into muscular dystrophy treatments and offer insights into cancer biology.PR NewswireVerismo Therapeutics Expands KIR-CAR Solid Tumor Treatment Pipeline with Novel Binder Developed at Penn Targeting Claudin 6 (CLDN6)Verismo Therapeutics announced a new preclinical KIR-CAR program targeting Claudin 6 (CLDN6) with a novel binder developed at the University of Pennsylvania. The program complements its lead mesothelin-targeting SynKIR-110, which is in Phase 1 trial STAR-101. CLDN6 is a validated solid tumor antigen with limited expression in healthy tissues.InsideprecisionmedicineHuman-Pig Interactions in Liver Xenotransplant Recipients: A Multi-Omics StudyResearchers from NYU Langone Health, NYU Grossman School of Medicine, and the Perelman School of Medicine at the University of Pennsylvania conducted a multi-omics analysis of extracorporeal liver cross-circulation using gene-edited porcine xenografts in four brain-dead human recipients over 84 hours. The study identified key immunological barriers including progressive infiltration of human innate immune cells expressing pro-inflammatory cytokines and distinct complement system behavior between species, along with mechanisms underlying thrombocytopenia. Findings suggest current complement inhibitors may be ineffective against pig-derived proteins, nominating new therapeutic targets and establishing a framework for improving xenograft biocompatibility through additional genetic engineering.Mirage News$10M Gift Fuels Trials for Rare Disease DrugThe Clayco Foundation has committed a $10 million gift to accelerate development of a novel small molecule degrader therapy for Retinal Vasculopathy with Cerebral Leukoencephalopathy (RVCL), a rare and fatal genetic disease caused by mutations in the TREX1 gene affecting approximately 200 patients worldwide. Researchers at the Perelman School of Medicine at the University of Pennsylvania, led by Dr. Jonathan Miner, will conduct pre-clinical safety trials for the therapy, which has shown life-saving results in mice carrying the human RVCL mutation. The drug works by binding to abnormal TREX1 proteins and an enzyme called E3 ligase, labeling the proteins for cellular destruction while leaving healthy proteins unaffected.GenengnewsAI Framework Surfaces New CAR T Target with Multi‑Cancer PotentialResearchers at the University of Pennsylvania developed an AI framework that identified GPNMB as a CAR T cell target, validated in preclinical models across melanoma, leukemia, and colorectal cancer. The study, published in Cell, suggests GPNMB's broad expression enables multi-cancer therapy. The team plans to apply the approach to additional cancer types.GenengnewsPerseverance, Persistence Key to CAR T Success, Say Ross Prize Winners Carl June and Michel SadelainCarl June and Michel Sadelain shared the 13th annual Ross Prize in Molecular Medicine for their pioneering CAR T-cell therapy work. Their research led to seven FDA-approved CAR T-cell therapies and over 60,000 patients treated. They noted challenges in solid tumors and in vivo CAR T-cell therapies as future directions.News-MedicalResearchers uncover nuclear organization mechanism linked to Friedreich's ataxiaResearchers at the University of Pennsylvania found that transcription and cohesin balance determine gene positioning in the nucleus, and this disruption contributes to Friedreich's ataxia. In patient cells, reducing cohesin moved the FXN gene away from the nuclear edge, partially restoring its expression. The findings suggest genome organization may be a therapeutic target.